Clinical and serological parameters in 28 patients with SLE
| Patients with | n (%) |
| Malar rash | 7 (25) |
| Discoid rash | 2 (7) |
| Photosensitivity | 15 (54) |
| Oral ulcers | 5 (18) |
| Arthritis/arthralgia | 22 (79) |
| Serositis | 7 (25) |
| Renal disorder | 19 (68) |
| Sicca syndrome | 7 (25) |
| Haematological disorder | |
| Haemolytic anaemia | 4 (14) |
| Leucopenia | 9 (32) |
| Thrombocytopenia | 5 (18) |
| Antinuclear antibody | 28 (100) |
| Anti-dsDNA antibody | 20 (71) |
| Antibodies against extractable nuclear antigens | 21 (75) |
| Sm | 12 (43) |
| nRNP | 12 (43) |
| Ro/SS-A | 13 (46) |
| La/SS-B | 9 (32) |
| Ribosomal P | 6 (21) |
| Low complement haemolytic activity (CH50)1-150 | 7 (25) |
| Increased plasma complement split product C3d | 18†/27 (67) |
↵1-150 30.3 (11.9) U/ml (normal range 20–50 U/ml). †15.4 (5.6) mg/l (normal range <10 mg/l).